DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC - a Sterile Dosage Manufacturing Facility in North Carolina, US, Strengthening Its Position in Developing and Manufacturing Complex Differentiated Sterile Dosage Formulations

DifGen Pharmaceuticals LLC (DifGen) announced that it has acquired KriGen LLC a fully integrated sterile drug product manufacturer with capability to manufacture a wide range of parenteral products including LVP bags (both Aseptic & Terminally Sterilized), PFS, Microspheres& complex Long Acting Injectables.

In a joint statement, Ramandeep Singh Jaj & Dr. Santhanakrishnan Srinivasan, Founders and Co-CEO's of DifGen commented, "Today marks an exciting & significant milestone for the entire DifGen family. The acquisition of KriGen LLC is expected to complement DifGen's strong scientific capability of developing complex injectable products. This strategic investment allows us the capability to manufacture complex and high-barrier to entry sterile products in-house. This helps secure supply to our valuable partners with local US based manufacturing. Most importantly, it will provide patients, affordable lifesaving medication with highest quality, consistent supply & ensure the burden of drug shortages are minimized."

Closing of the transaction is subject to the customary regulatory approvals.